• Subscribe to Huron Insights
  • Submit RFP
  • Investor Relations
  • Careers
  • Contact Us

  • Industry
    • Aerospace
    • Automotive
    • Energy & Utilities
    • Financial Services
    • Government
    • Healthcare
    • Higher Education
    • Hospitality & Gaming
    • Life Sciences
    • Logistics
    • Manufacturing
    • Metals & Mining
    • Retail & Consumer Products
    • Technology, Media & Telecommunications
  • Expertise
    • Business Advisory
    • Enterprise Solutions & Analytics
    • Technology
  • Resources
  • Company
    • About Us
    • Contact Us
    • Locations
    • Our Experts
    • Leadership
    • Press Releases
    • Diversity & Community Affairs
    • Careers
HigherEd_ThoughtLeadership_Resize

Clinical Research Management Briefing - May 21, 2018

Contact Us Contact Us

Top Stories

Europe’s Data Protection Law Is a Big, Confusing Mess

This week, the European Union will start to enforce new regulations under the General Data Protection Regulation (GDPR) about how personal data is collected and protected – whether or not the policy is understood.

The New York Times, May 15

USAF, NSF Partner for National Security R&D Effort

The U.S. Air Force (USAF) and the National Science Foundation (NSF) will begin working together to increase research and development in the areas of space, geoscience and data science.

ExecutiveGov, May 10

 

Regulatory

NIH: ‘If We Don’t Report Our Results We Will Repeat Mistakes’

Regulatory agencies are doubling down on compliance – and withholding funds – as the clinical research industry enters an era of accountability and transparency, say NIH officials.

Outsourcing-Pharma, May 16

HHS Announces Planned Rules Affecting IRBs and Clinical Trials

The Department of Health and Human Services (HHS) is due to announce several proposed rules regarding Institutional Review Boards (IRBs) and clinical trials.

CenterWatch, May 14

 

Financial and Operations

Experts Debate Methods to Overcome Clinical Trial Enrollment Barriers

Research experts gathered to discuss ways to increase enrollment by improving social, economic and patient awareness barriers.

CenterWatch, May 14

 

Technology

Blockchain Concepts Emerge in Clinical Trials

The head of new clinical paradigms at Pfizer shares the current trends and his predictions for blockchain use in the pharmaceutical industry.

Applied Clinical Trials, May 8

 

Spotlight

FDA Issues Final Guidance in Effort to Protect Clinical Trial Participants

Tom Bechert, director at Huron, comments on the Food and Drug Administration’s (FDA’s) final guidance in its efforts to improve protection for participants in clinical trials and reduce regulatory burden.

Outsourcing-Pharma, May 17

Contact Us

Related Articles

  • Clinical Research Management Briefing - May 14, 2018
  • Clinical Research Management Briefing - May 7, 2018
  • Clinical Research Management Briefing - April 30, 2018
Share:
Contact Us Contact Us

Subscribe to Huron Insights

Sign Up Today!

Clinical Research Management Briefing - May 21, 2018

  • Rick Rohrbach

    Rick Rohrbach

    Managing Director

    Industry:

    Higher Education | Healthcare | Technology Media and Telecommunications | Life Sciences | Retail

    Contact Me LinkedIn Read My Bio
  • Leah Guidry

    Leah Guidry

    Managing Director

    Industry:

    Higher Education | Healthcare | Life Sciences

    Contact Me LinkedIn Read My Bio
+
  • Facebook Icon
  • Google Plus Icon
  • Linkedin Icon
  • Twitter Icon

© 2019 Huron Consulting Group Inc. and affiliates. All rights reserved. Huron is a global consultancy and not a CPA firm, and does not provide attest services, audits, or other engagements in accordance with standards established by the AICPA or auditing standards promulgated by the Public Company Accounting Oversight Board ("PCAOB"). Huron is the trading name of Pope Woodhead & Associates Ltd.

We use cookies on our website to provide you with a more personalized digital experience, enable website functionality and understand the performance of our site. You may review our Privacy Statement and our Cookies Policy. By using this site you agree to our use of cookies. I Accept

  • Privacy Statement
  • Terms & Conditions
  • Cookies Policy
  • Fraudulent Offers